Yimmugo 100 mg/ml Infusionslösung New

Recall | Medicines | 12/05/2026

The marketing authorisation holder notified its customers, on May 12, 2026, that the specified batch is being recalled due to an increased number of adverse event reports.

Name of the medicinal product Yimmugo 100 mg/ml Infusionslösung
Marketing authorisation number(s) 2-41499
CIP code 5520388
Marketing authorisation holder Biotest Pharma GmbH
Batch number(s) C795945P02
Expiry date 05/31/2028
Classification of the recall2
Depth of recall Pharmacies
BASG reference number INS-640.001-5669
Email

Further inquiry note